Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCV and PPS Vaccination Regimens in Fijian Infants
NCT00170612Phase 2Completed
- Sponsor
- University of Melbourne
- Start
- Nov 2005
- Primary completion
- Jan 2008
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of pneumococcal 7-valent conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal infection, sponsored by University of Melbourne. Primary endpoint: Proportion of children responding to the micro-PPS dose. Started Nov 2005; status: completed.
02
Drugs
pneumococcal 7-valent conjugate vaccine23-valent pneumococcal polysaccharide vaccine
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT00170612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00170612.